Increasing global travel and rapid viral evolution continues to fuel annual flu epidemics. While widespread public health vaccination campaigns help prevent some infections, the efficacy of the vaccine varies – depending on the dominant strains each year.

An estimated 45 million Americans were infected by the influenza virus in the 2017-2018 season resulting in over 800,000 hospitalizations and 61,000 deaths. In 2020 28.2 million Americans contracted SARS-CoV-2, resulting in 500,000 deaths. Worldwide, 120+ million have tested COVID-19 positive, and over 2.5+ million have died.

The Seraph Research team is developing new treatments to reduce the severity and length of infection and help prevent the high number of deaths each year.